The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer

被引：2
|
作者：
Chen, Yen-Yin [1 ,2 ,3 ,4 ]
Yang, Ching-Fe [3 ,4 ]
Hsu, Chih-Yi [3 ,4 ,5 ]
机构：
[1] Taipei Med Univ, Shuang Ho Hosp, Dept Pathol, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Sch Med, Dept Pathol, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[5] Natl Taipei Univ Nursing & Hlth Sci, Coll Nursing, Taipei, Taiwan
来源：
PATHOLOGY | 2024年 / 56卷 / 01期
关键词：
EXPRESSION; FIXATION;
D O I：
10.1016/j.pathol.2023.06.002
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：122 / 124
页数：3
相关论文
共 50 条
  • [1] Immunohistochemical double staining with estrogen receptor and HER2 on primary breast cancer
    Horiguchi, J
    Koibuchi, Y
    Iijima, K
    Yoshida, T
    Yoshida, M
    Takata, D
    Oyama, T
    Iino, Y
    Morishita, Y
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (06) : 855 - 859
  • [2] Image Analysis of HER2 Immunohistochemical Staining of Surgical Breast Cancer Specimens
    Yim, Kwangil
    Park, Hong Sik
    Kim, Dong Min
    Lee, Youn Soo
    Lee, Ahwon
    YONSEI MEDICAL JOURNAL, 2019, 60 (02) : 158 - 162
  • [3] Nonmembranous HER2/neu immunohistochemical staining
    Vera-Román, JM
    Rubio, L
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (04): : 364 - 365
  • [4] HER2 staining intensity has prognostic impact on patients with HER2 type invasive breast cancer
    Yi-Hsuan, H.
    Yen-Shu, L.
    Chih-Yi, H.
    Ling-Ming, T.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles
    Zhang, Huina
    Katerji, Hani
    Turner, Bradley M.
    Audeh, William
    Hicks, David G.
    MODERN PATHOLOGY, 2022, 35 (08) : 1075 - 1082
  • [6] HER2-Low Breast Cancer Can Be Visualized by HER2 PET
    Altena, Renske
    af Buren, Siri
    Tran, Thuy
    Axelsson, Rimma
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1842 - 1842
  • [7] Improving HER2 testing reproducibility in HER2-low breast cancer
    Sajjadi, Elham
    Venetis, Konstantinos
    Ivanova, Mariia
    Fusco, Nicola
    CANCER DRUG RESISTANCE, 2022, 5 (04) : 882 - 888
  • [8] Dual Contribution of Quantitative Image Analysis for the Evaluation of HER2 IHC Staining Quality, and Interpretation of HER2 Overexpression and HER2-Low Status in Breast Carcinoma
    Cossutta, Melissande
    Truumees, Birgit
    Papine, Alexandre
    Kristoffersen, Heidi
    Tatarinova, Ekaterina
    Homsy, Charles
    Nielsen, Soren
    Soussaline, Francoise
    LABORATORY INVESTIGATION, 2024, 104 (03) : S139 - S140
  • [9] The relationship between HER2 immunohistochemical staining patterns and treatment response in breast cancer
    Cesur, M. Erdal
    Aker, F.
    VIRCHOWS ARCHIV, 2024, 485 : S192 - S193
  • [10] EFFECT OF FORMALIN FIXATION ON IMMUNOHISTOCHEMICAL STAINING FOR HER2
    Yamashita-Kashima, Y.
    Shu, S.
    Yorozu, K.
    Iwai, T.
    Hashizume, K.
    Fujimoto-Ouchi, K.
    Harada, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 132 - 132
12345